Stock Comparison
ARGX vs JAZZ
argenx NV ADR and Jazz Pharmaceuticals PLC side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$55.44B
$14.45B
P/E (TTM)
39.4
1,916.8
Forward P/E
34.0
12.6
Price/Sales
11.7
3.3
Price/Book
7.5
3.2
EV/EBITDA
33.9
25.2
Dividend Yield
—
—
Profitability
Net Margin
31.40%
0.66%
Operating Margin
30.00%
23.50%
Return on Equity
20.20%
0.68%
Return on Assets
8.86%
6.92%
Growth (YoY)
Revenue Growth
62.60%
19.10%
Earnings Growth
114.00%
3.20%
Price & Risk
Beta
-0.0
0.3
52-Week High
$934.62
$243.32
52-Week Low
$510.06
$105.00
Analyst Target
$1,041.14
$257.00
Compare ARGX and JAZZ your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.